Showing results (181-190 of 263) with videos related to

Sort By:
Pageof 27
Arthritis and Rheumatism|June 3, 2008
Onset of psoriatic arthritis in patients treated with efalizumab for moderate to severe psoriasisManuelle Viguier, Pascal Richette, François Aubin, et al.
Annals of the Rheumatic Diseases|May 31, 2011
Assessment of dynamic humeral centering in shoulder pain with impingement syndrome: a randomised clinical trialJohann Beaudreuil, Sandra Lasbleiz, Pascal Richette, et al.
Joint Bone Spine|August 24, 2010
Efficacy of a functional restoration program for chronic low back pain: prospective 1-year studyJohann Beaudreuil, Hinna Kone, Sandra Lasbleiz, et al.
RMD Open|March 31, 2023
Identification of PsA phenotypes with machine learning analytics using data from two phase III clinical trials of guselkumab in a bio-naïve population of patients with PsAPascal Richette, Marijn Vis, Sarah Ohrndorf, et al.
Plos One|May 22, 2015
Online training on skin cancer diagnosis in rheumatologists: results from a nationwide randomized web-based surveyManuelle Viguier, Stéphanie Rist, François Aubin, et al.
Arthritis Care & Research|October 20, 2022
Identification of Symptom Phenotypes of Hand Osteoarthritis Using Hierarchical Clustering: Results From the DIGICOD CohortMarie Binvignat, Gabriel Pires, Nicolas Tchitchek, et al.
Rheumatology (Oxford, England)|December 5, 2021
Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritisPeter Nash, Pascal Richette, Laure Gossec, et al.
Joint Bone Spine|July 1, 2022
Spine abnormalities associated with bone edema on sacroiliac joints MRI in patients with non-inflammatory chronic back painGuillaume Marnas, Chloé Bernardy, Anthony Cole, et al.
Muscle & Nerve|April 14, 2012
Muscle magnetic resonance imaging sensitivity does not decrease in chronic, mild, or proximal lower limb neuropathiesNicolas Deroide, Valérie Bousson, Edouard Daguet, et al.
Joint Bone Spine|September 26, 2020
UltraSound evaluation in follow-up of urate-lowering therapy in gout phase 2 (USEFUL-2): Duration of flare prophylaxisEsther Ebstein, Marine Forien, Eleonora Norkuviene, et al.
Pageof 27